HealthTech

SonderMind Expands Personalized Mental Healthcare Servi...

What You Should Know:  – SonderMind, a provider of comprehensive, personalized m...

Eli Lilly sues Empower, Strive over tirzepatide products

Eli Lilly has sued two large compounding pharmacies, alleging they deceive patie...

MedeAnalytics Launches Health Fabric™ on Snowflake AI D...

What You Should Know:  – MedeAnalytics, a provider of healthcare enterprise data...

Venteur Raises $20M to Expand Personalized Health Benef...

What You Should Know: – Venteur, a personalized health technology platform secur...

FDA cuts hit drug ad review office, in seeming contradi...

HHS Secretary Robert F. Kennedy Jr. has made clear that he would like to ban dir...

Tech-enabled Eargo, hearX merge to form new hearing aid...

LXE Hearing received $100 million in financing from Patient Square Capital.

European regulator proposal would ‘streamline’ biosimil...

The European Medicines Agency is looking to simplify the way it approves biosimi...

Texas judge strikes down FDA rule on lab-developed test...

The judge ruled that the FDA overstepped its authority by regulating LDTs as med...

AvaSure Acquires Nurse Disrupted to Advane Clinically-D...

What You Should Know: –  AvaSure, the leader in AI-powered virtual care virtual ...

Locke Bio Partners with imaware to Bring Comprehensive ...

What You Should Know: –  Locke Bio, a leading telehealth platform, has partnered...

Zus Health CEO Jonathan Bush on the future of health re...

My primary care doctor and my OB-GYN have no idea what each other did or prescri...

Unleash Your Data Archives to Empower Your AI Efforts

MediQuant, according CEO Jim Jacobs, is an “active archive” service, in business...

Gubra’s AbbVie-partnered amylin looks competitive with ...

GUBamy, the amylin obesity candidate developed by Gubra and licensed to AbbVie f...

Q&A: Isomorphic Labs CEO Demis Hassabis on $600M raise,...

Isomorphic Labs wants to achieve "maximum acceleration" on its drug discovery re...

Compass Therapeutics cancer trial succeeds, needs more ...

Compass Therapeutics said Tuesday that adding its bispecific antibody to chemoth...

Axsome reports Phase 3 depression fail for Sunosi

Axsome Therapeutics said Tuesday that a Phase 3 trial for its narcolepsy drug Su...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.